Forecasting antiretroviral and diagnostic needs

April 2005
WHO Drug Information;2005, Vol. 19 Issue 2, p129
Academic Journal
Forecasts the accessibility of people with HIV/AIDS to antiretrovirals and diagnostics. Efforts of the World Health Organization to provide treatment to people with HIV/AIDS; Factors that are essential to the success of the WHO initiative; Examination of the best practices and problems in quantifying antiretrovirals and diagnostics for the treatment of HIV patients.


Related Articles

  • Facilitators and Barriers of Antiretroviral Therapy Initiation among HIV Discordant Couples in Kenya: Qualitative Insights from a Pre-Exposure Prophylaxis Implementation Study. Patel, Rena C.; Odoyo, Josephine; Anand, Keerthana; Stanford-Moore, Gaelen; Wakhungu, Imeldah; Bukusi, Elizabeth A.; Baeten, Jared M.; Brown, Joelle M. // PLoS ONE;12/8/2016, Vol. 11 Issue 12, p1 

    Introduction: The World Health Organization now recommends antiretroviral therapy (ART) initiation for all HIV-infected individuals regardless of CD4 cell count or disease status. Understanding the facilitators and barriers to initiation of and adherence to ART is essential to successful...

  • Quality of life of People living with HIV and AIDS attending the Antiretroviral Clinic, University College Hospital, Nigeria. Folasire, Oluyemisi F.; Irabor, Achiaka E.; Folasire, Ayorinde M. // African Journal of Primary Health Care & Family Medicine;2012, Vol. 4 Issue 1, p1 

    Background: Quality of life (QOL) is an important component in the evaluation of the well-being of people living with HIV and AIDS (PLWHA), especially with the appreciable rise in longevity of PLWHA. Moreover, limited studies have been conducted in Nigeria on how PLWHA perceive their life with...

  • Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIVUnrelated Mortality. Brinkhof, Martin W. G.; Boulle, Andrew; Weigel, Ralf; Messou, Eugène; Mathers, Colin; Orrell, Catherine; Dabis, François; Pascoe, Margaret; Egger, Matthias // PLoS Medicine;Apr2009, Vol. 6 Issue 4, p1 

    Background: Mortality in HIV-infected patients who have access to highly active antiretroviral therapy (ART) has declined in sub-Saharan Africa, but it is unclear how mortality compares to the non-HIV-infected population. We compared mortality rates observed in HIV-1-infected patients starting...

  • The Global Status of HIV Drug Resistance: Clinical and Public-Health Approaches for Detection, Treatment and Prevention. Hong, Steven Y.; Nachega, Jean B.; Kelley, Karen; Bertagnolio, Silvia; Marconi, Vincent C.; Jordan, Michael R. // Infectious Disorders - Drug Targets;Apr2011, Vol. 11 Issue 2, p124 

    No abstract available.

  • A Retrospective Survey of HIV Drug Resistance Among Patients 1 Year After Initiation of Antiretroviral Therapy at 4 Clinics in Malawi. Wadonda-Kabondo, Nellie; Hedt, Bethany L.; van Oosterhout, Joep J.; Moyo, Kundai; Limbambala, Eddie; Bello, George; Chilima, Ben; Schouten, Erik; Harries, Anthony; Massaquoi, Moses; Porter, Carol; Weigel, Ralf; Hosseinipour, Mina; Aberle-Grasse, John; Jordan, Michael R.; Kabuluzi, Storn; Bennett, Diane E. // Clinical Infectious Diseases;May2012 Supplement 4, Vol. 54 Issue suppl_4, pS355 

    In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limited treatment options, population-level surveillance of acquired human immunodeficiency virus drug resistance (HIVDR) is critical to ensuring long-term treatment success. The World Health...

  • Making Dreams a Reality. Koppal, Tanuja // Drug Discovery & Development;Jul2006, Vol. 9 Issue 7, p4 

    The article discusses the progress of AIDS treatment since the discovery of the disease in 1981. It has been expected that there will be more than 30 drugs available to AIDS patients in the next few years that will improve patient tolerance and compliance. In addition, many programs were...

  • Role of the US President's Emergency Plan for AIDS Relief in Responding to Tuberculosis and HIV Coinfection. Coggin, William L.; Ryan, Caroline A.; Holmes, Charles B. // Clinical Infectious Diseases;May2010 Supplement 3, Vol. 50, pS255 

    The intersection of tuberculosis (TB) and human immunodeficiency virus (HIV) infection has eroded gains made in TB control, because previously well-functioning national TB programs have been overwhelmed by the dual challenges posed by TB and HIV coinfection. The US President's Emergency Plan for...

  • Do Benefits of Earlier Antiretroviral Treatment Initiation Outweigh Harms for Individuals at Risk for Poor Adherence? Braithwaite, R. Scott; Roberts, Mark S.; Goetz, Matthew Bidwell; Gibert, Cynthia L.; Rodriguez-Barradas, Maria C.; Nucifora, Kimberly; Justice, Amy C. // Clinical Infectious Diseases;3/15/2009, Vol. 48 Issue 6, p822 

    Clinicians may defer antiretroviral treatment for patients with suboptimal adherence. We used a validated computer simulation of HIV disease progression to compare alternative treatment thresholds for patients with suboptimal adherence. Earlier treatment increased life expectancy across a wide...

  • Medication Adherence and Sexual Risk Behavior among HIV-Infected Adults: Implications for Transmission of Resistant Virus. Remien, Robert H.; Exner, Theresa M.; Morin, Stephen F.; Ehrhardt, Anke A.; Johnson, Mallory O.; Correale, Jackie; Marhefka, Stephanie; Kirshenbaum, Sheri B.; Weinhardt, Lance S.; Rotheram-Borus, Mary Jane; Catz, Sheryl L.; Gore-Felton, Cheryl; Chesney, Margaret A.; Kelly, Jeffrey // AIDS & Behavior;Sep2007, Vol. 11 Issue 5, p663 

    As more people are living long-term with HIV there are growing concerns about specific behaviors that can affect both personal and the public health. This study examined the relationship between antiretroviral therapy (ART) adherence and sexual risk behavior and their association with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics